Notch3 pathway alterations in ovarian cancer

Cancer Research

Volumn 74, Issue 12, 2014, Pages 3282-3293

  Hu, Wei ^a   Liu, Tao ^a,b   Ivan, Cristina ^a   Sun, Yunjie ^a   Huang, Jie ^a   Mangala, Lingegowda S ^a   Miyake, Takahito ^a   Dalton, Heather J ^a   Pradeep, Sunila ^a   Rupaimoole, Rajesh ^a   Previs, Rebecca A ^a   Han, Hee Dong ^a   Bottsford Miller, Justin ^a   Zand, Behrouz ^a   Kang, Yu ^a   Pecot, Chad V ^a   Nick, Alpa M ^a   Wu, Sherry Y ^a   Lee, Ju Seog ^a   Sehgal, Vasudha ^a   Ram, Prahlad ^a   Liu, Jinsong ^a   Tucker, Susan L ^a   Lopez Berestein, Gabriel ^a   Baggerly, Keith A ^a   Coleman, Robert L ^a   Sood, Anil K ^a   more..

^a UNIVERSITY OF TEXAS   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMIN; JAGGED1; NOTCH3 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DLL3 GENE; ENDOCYTOSIS; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; JAG1 GENE; MAJOR CLINICAL STUDY; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; NOTCH3 GENE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SNW1 GENE; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; DYNAMINS; ENDOCYTOSIS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PACLITAXEL; RECEPTORS, NOTCH; RNA, SMALL INTERFERING; TRANSCRIPTOME; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84903436202     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2066     Document Type: Article

References (20)

1. Chan YM, Jan YN. Roles for proteolysis and trafficking in notch maturation and signal transduction. Cell 1998;94:423-6. (Pubitemid 28391858)
2. Artavanis-Tsakonas S, Muskavitch MA. Notch: the past, the present, and the future. Curr Top Dev Biol 2010;92:1-29.
3. Wang Z, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D, et al. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim Biophys Acta 2010;1806:258-67.
4. TCGA Research Group. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-15.
5. Cooke SL, Brenton JD. Evolution of platinum resistance in high-grade serous ovarian cancer. Lancet Oncol 2011;12:1169-74.
6. Landen CN Jr, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 2008;26:995-1005. (Pubitemid 351398093)
7. Saad AF, Hu W, Sood AK. Microenvironment and pathogenesis of epithelial ovarian cancer. Horm Cancer 2010;1:277-90.
8. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell 2010;18:185-97.
9. Smyth GK. Limma: linear models for microarray data. In Bioinformatics and computational biology: solutions using R and bioconductor. New York, NY:Springer; 2005.
10. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8. (Pubitemid 29003722)
11. Komurov K, Dursun S, Erdin S, Ram PT. NetWalker: a contextual network analysis tool for functional genomics. BMC Genomics 2012;13:282.
12. Wong GW, Knowles GC, Mak TW, Ferrando AA, Zuniga-Pflucker JC. HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRbeta-selected mouse thymocytes. Blood 2012;120:1439-48.
13. Serafin V, Persano L, Moserle L, Esposito G, Ghisi M, Curtarello M, et al. Notch3 signalling promotes tumour growth in colorectal cancer. J Pathol 2011;224:448-60.
14. Bellavia D, Checquolo S, Campese AF, Felli MP, Gulino A, Screpanti I. Notch3: from subtle structural differences to functional diversity. Oncogene 2008;27:5092-8.
15. Chen X, Stoeck A, Lee SJ, Shih Ie M, Wang MM, Wang TL. Jagged1 expression regulated by Notch3 and Wnt/beta-catenin signaling pathways in ovarian cancer. Oncotarget 2010;1:210-8.
16. Yamamoto S, Charng WL, Bellen HJ. Endocytosis and intracellular trafficking of Notch and its ligands. Curr Top Dev Biol 2010;92:165-200.
17. Meloty-Kapella L, Shergill B, Kuon J, Botvinick E, Weinmaster G. Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin. Dev Cell 2012;22:1299-312.
18. Le Borgne R, Bardin A, Schweisguth F. The roles of receptor and ligand endocytosis in regulating Notch signaling. Development 2005;132:1751-62. (Pubitemid 40691766)
19. Kirchhausen T, Macia E, Pelish HE. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol 2008;438:77-93.
20. Masaike Y, Takagi T, Hirota M, Yamada J, Ishihara S, Yung TM, et al. Identification of dynamin-2-mediated endocytosis as a new target of osteoporosis drugs, bisphosphonates. Mol Pharmacol 2010;77:262-9.